DICERNA PHARMACEUTICALS INC (DRNA)
Institutional ownership reported to the SEC as of Q1 2022, across 14 quarters.
1
Reporting holders
$76.0K
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Close Asset Management Ltd | $76.0K | 2,000 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2022 | 1 | $76.0K | 2,000 | 0 | 0 | 0 | 0.0% |
| Q4 2021 | 2 | $169.0K | 2,000 | 0 | 0 | 0 | 55.0% |
| Q3 2021 | 176 | $1.3B | 63,331,960 | 30 | 60 | 56 | 1.5% |
| Q2 2021 | 205 | $2.3B | 62,053,275 | 43 | 61 | 62 | 0.8% |
| Q1 2021 | 185 | $1.6B | 63,218,910 | 34 | 50 | 67 | 0.8% |
| Q4 2020 | 177 | $1.4B | 63,795,216 | 23 | 53 | 68 | 0.6% |
| Q3 2020 | 173 | $1.1B | 61,129,142 | 30 | 66 | 54 | 1.4% |
| Q2 2020 | 174 | $1.6B | 62,632,754 | 38 | 63 | 52 | 0.4% |
| Q1 2020 | 146 | $1.1B | 61,653,945 | 12 | 50 | 53 | 0.1% |
| Q4 2019 | 170 | $1.3B | 58,473,360 | 60 | 50 | 40 | 0.4% |
| Q3 2019 | 112 | $840.7M | 58,170,611 | 28 | 30 | 33 | 0.0% |
| Q2 2019 | 99 | $903.0M | 56,851,475 | 18 | 33 | 27 | 0.1% |
| Q1 2019 | 98 | $872.0M | 59,195,531 | 20 | 33 | 24 | 0.0% |
| Q4 2018 | 103 | $628.4M | 58,772,374 | 2 | 5 | 1 | 0.0% |